Significantly higher pharyngeal shedding of Epstein-Barr virus (EBV) is observed during HIV infection. Increased EBV shedding in pharynx is not affected even during highly active antiretroviral theyrapy (HAART). EBV positive monocyte populations have been shown to carry EBV to pharyngeal mucosa. Human cytokine profiles are often altered to facilitate herpes virus infection. Thus pharyngeal cytokine profiles may influence EBV reactivation and shedding during HIV infection. Our objective was to compare 37 pharyngeal cytokine profiles of HIV-seropositive patients who were or were not receiving HAART therapy.
Digital Object Identifier (DOI)
Perera, R. A. P. M.; Tsang, P. C. S.; Miller, Craig S.; Li, P.; Lee, M. P.; and Samaranayake, L. P., "Identification of differential pharyngeal cytokine profiles during HIV infection" (2011). Center for Oral Health Research Presentations. 1.